Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,239 | 23,233 | 0 | 0 | 0 |
| Marketable Securities | 110,483 | 63,310 | 0 | 0 | 0 |
| TOTAL | $135,767 | $88,007 | $0 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 275 | 88 | N/A | N/A | N/A |
| Other Non-Current Assets | 217 | 1,808 | 0 | 0 | 0 |
| TOTAL | $492 | $1,896 | $N/A | $N/A | $N/A |
| Total Assets | $136,259 | $89,903 | $0 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,225 | 1,452 | 0 | 0 | 0 |
| Accrued Expenses | 3,590 | 2,175 | 0 | 0 | 0 |
| TOTAL | $7,035 | $4,847 | $0 | $0 | $0 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,220 | 1,220 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 243 | 2,918 | 0 | 0 | 0 |
| TOTAL | $15,378 | $18,358 | $N/A | $N/A | $N/A |
| Total Liabilities | $22,413 | $23,205 | $0 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,782 | N/A | N/A | N/A | N/A |
| Common Shares | 2 | 1 | 0 | 0 | 0 |
| Retained earnings | -271,151 | -259,675 | 0 | 0 | 0 |
| Other shareholders' equity | 228 | 326,372 | 0 | 0 | 0 |
| TOTAL | $113,846 | $66,698 | $0 | $0 | $0 |
| Total Liabilities And Equity | $136,259 | $89,903 | $0 | $0 | $0 |